Uncategorized
Health

University of Pennsylvania develops breakthrough experimental leukemia treatment

A team of researchers at Penn has developed an experimental treatment for leukemia that’s being billed as a “major breakthrough” in the field, the New York Times reported. The Times profiled one patient — a 7-year-old girl who had relapsed twice after chemotherapy — who underwent the treatment at the Children’s Hospital of Philadelphia. Seven […]

Dr. Carl June is leading a team of Penn researchers that developed an experimental treatment for leukemia that’s being billed as a “major breakthrough.” Photo courtesy of underthebutton.com

A team of researchers at Penn has developed an experimental treatment for leukemia that’s being billed as a “major breakthrough” in the field, the New York Times reported.

The Times profiled one patient — a 7-year-old girl who had relapsed twice after chemotherapy — who underwent the treatment at the Children’s Hospital of Philadelphia. Seven months later, she is still in remission, the Times reported.

From the article:

She is among just a dozen patients with advanced leukemia to have received the experimental treatment, which was developed at the University of Pennsylvania. Similar approaches are also being tried at other centers, including the National Cancer Institute and Memorial Sloan-Kettering Cancer Center in New York.

“Our goal is to have a cure, but we can’t say that word,” said Dr. Carl June, who leads the research team at the University of Pennsylvania. He hopes the new treatment will eventually replace bone-marrow transplantation, an even more arduous, risky and expensive procedure that is now the last hope when other treatments fail in leukemia and related diseases.

Read the whole article here.

Companies: University of Pennsylvania

Before you go...

Please consider supporting Technical.ly to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.

3 ways to support our work:
  • Contribute to the Journalism Fund. Charitable giving ensures our information remains free and accessible for residents to discover workforce programs and entrepreneurship pathways. This includes philanthropic grants and individual tax-deductible donations from readers like you.
  • Use our Preferred Partners. Our directory of vetted providers offers high-quality recommendations for services our readers need, and each referral supports our journalism.
  • Use our services. If you need entrepreneurs and tech leaders to buy your services, are seeking technologists to hire or want more professionals to know about your ecosystem, Technical.ly has the biggest and most engaged audience in the mid-Atlantic. We help companies tell their stories and answer big questions to meet and serve our community.
The journalism fund Preferred partners Our services
Engagement

Join our growing Slack community

Join 5,000 tech professionals and entrepreneurs in our community Slack today!

Trending

Cal Ripken Jr. essay: The MLB legend explains his drive to build STEM centers in schools across the nation

How 3 local orgs help founders and entrepreneurs build their networks

Hopeworks to double Kensington student base with $1 million expansion in Philly

The end of software as technology

Technically Media